Informa’s (INF) Buy Rating Reaffirmed at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reissued their buy rating on shares of Informa (LON:INF) in a report released on Friday morning,Digital Look reports. Deutsche Bank Aktiengesellschaft currently has a GBX 1,140 price objective on the stock.

Other research analysts also recently issued research reports about the company. Berenberg Bank increased their price objective on Informa from GBX 965 to GBX 1,040 and gave the company a “buy” rating in a report on Friday. JPMorgan Chase & Co. decreased their target price on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research note on Thursday, July 2nd. Finally, Citigroup lowered their price target on Informa from GBX 1,000 to GBX 850 and set a “neutral” rating for the company in a report on Thursday, April 9th. Five research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,095.

Informa Stock Performance

Shares of INF stock opened at GBX 903.46 on Friday. The company has a current ratio of 0.55, a quick ratio of 1.70 and a debt-to-equity ratio of 64.99. The firm has a fifty day moving average price of GBX 864.03 and a 200 day moving average price of GBX 833.15. The company has a market cap of £11.33 billion, a P/E ratio of 1,129.33, a PEG ratio of 0.75 and a beta of 0.69. Informa has a 12 month low of GBX 719 and a 12 month high of GBX 1,000.

Informa (LON:INF) last posted its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share for the quarter. Informa had a return on equity of 3.90% and a net margin of 5.43%. Sell-side analysts predict that Informa will post 59.3240265 earnings per share for the current fiscal year.

Insider Buying and Selling at Informa

In related news, insider Stephen A. Carter acquired 222 shares of the firm’s stock in a transaction on Wednesday, May 20th. The stock was bought at an average price of GBX 809 per share, for a total transaction of £1,795.98. Also, insider Gareth Wright acquired 222 shares of the company’s stock in a transaction on Wednesday, May 20th. The shares were purchased at an average cost of GBX 809 per share, for a total transaction of £1,795.98. 0.39% of the stock is owned by company insiders.

Key Informa News

Here are the key news stories impacting Informa this week:

• Positive Sentiment: Higher full-year guidance: Informa raised its fiscal-year outlook as first-half growth strengthened, signaling confidence in continued demand across its events, publishing and digital businesses. Informa lifts FY guidance as H1 growth strengthens
• Positive Sentiment: Healthy B2B events performance: The B2B Live Events division delivered 8% underlying revenue growth in the first half. Although some IMEA events were rescheduled, the underlying trend indicates resilient corporate and professional-event demand. Informa H1 2026 Trading Update
• Positive Sentiment: Broker support increased: Berenberg raised its price target from GBX 965 to GBX 1,040 and initiated or reaffirmed a “buy” rating. Deutsche Bank also reaffirmed “buy” with a GBX 1,140 target, implying substantial upside to the recent trading level. Broker views from Digital Look
• Neutral Sentiment: Informa reported quarterly earnings of GBX 26.70 per share. The result provides additional financial confirmation, but the raised outlook and forward guidance are likely more important to the market than the headline quarterly figure.
• Neutral Sentiment: Recent partnerships involving Informa TechTarget, BrightTALK and the fashion supply chain expand the company’s industry reach, but their near-term financial impact is unclear.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.